固形腫瘍治療薬の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Solid Tumors Drugs Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Assumptions
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights
• Markers used for diagnosis of solid tumors

PART 05: Cost analysis

PART 06: Pipeline portfolio
• Anticipated number of products with single and multiple indications by 2020

PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis

PART 08: Market segmentation by molecule type
• Small molecules
• Biologics

PART 09: Market segmentation by type of therapy
• Chemotherapy
• Hormone therapy
• Targeted therapy
• Immunotherapy

PART 10: Market segmentation by disease
• Global breast cancer drugs market
• Global NHL drugs market
• Global colorectal cancer drugs market
• Global NSCLC drugs market
• Global prostate cancer drugs market
• Global kidney cancer drugs market
• Global retinoblastoma drugs market
• Global cervical cancer market
• Global melanoma drugs market
• Global gastric cancer drugs market
• Global pancreatic cancer drugs market
• Global ovarian cancer drugs market
• Global liver cancer drugs market
• Global HL drugs market
• Global glioblastoma multiforme drugs market

PART 11: Geographical segmentation
• Solid tumors drugs market in Americas
• Solid tumors drugs market in EMEA
• Solid tumors drugs market in APAC

PART 12: Market drivers
• Patient assistance programs
• Exposure to risk factors
• Provision for rare diseases
• Promising pipeline
• Increase in prevalence of solid tumors

PART 13: Impact of drivers

PART 14: Market challenges
• Patent expiration of top-selling drugs
• Poor diagnosis and screening
• High cost of drugs
• Availability of chemotherapy and off-label drugs
• Stringent regulations

PART 15: Impact of drivers and challenges

PART 16: Market trends
• Increase in cancer awareness
• Emergence of targeted and combination therapies
• Emergence of biosimilars
• Joint ventures and partnerships for R&D
• Increase in use of brachytherapy

PART 17: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• F. Hoffmann-La Roche
• Novartis
• Celgene
• Johnson & Johnson
• Pfizer
• BMS
• Other prominent vendors

PART 18: Appendix
• List of abbreviations

PART 19: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Types of solid tumors
Exhibit 03: Markers used for types of solid tumors
Exhibit 04: Annual treatment cost per patient for solid tumor drugs 2014
Exhibit 05: Average cost of surgeries associated with solid tumors 2014 ($)
Exhibit 06: Average cost of chemotherapy 2014 ($)
Exhibit 07: Average cost of radiation therapy 2014 ($)
Exhibit 08: Phase III pipeline molecules for solid tumors
Exhibit 09: Phase II pipeline molecules for solid tumors
Exhibit 10: Phase I pipeline molecules for solid tumors
Exhibit 11: Pre-clinical pipeline molecules for solid tumors
Exhibit 12: Pipeline share of solid tumors drugs 2015
Exhibit 13: Near-launch immuno-oncology pipeline assets 2020
Exhibit 14: Global solid tumors market 2015-2020 ($ billions)
Exhibit 15: Factors influencing global solid tumors drugs market 2015
Exhibit 16: Five forces analysis
Exhibit 17: Segmentation of global solid tumors drugs market by type of molecules 2015
Exhibit 18: Market segmentation by disease
Exhibit 19: Global solid tumors drugs market: Segmentation by disease 2015
Exhibit 20: Global solid tumors drugs market: YoY revenue and growth based on drug class 2015-2020 ($ billions)
Exhibit 21: Stages of breast cancer based on tumor size and extent of metastasis
Exhibit 22: Classification of breast cancer based on genetic makeup of tumor cells
Exhibit 23: Treatment regimen for breast cancer
Exhibit 24: Product offerings for breast cancer drugs market
Exhibit 25: Global breast cancer drugs market 2015-2020 ($ billions)
Exhibit 26: Product offerings for global NHL drugs market
Exhibit 27: Global NHL drugs market 2015-2020 ($ billions)
Exhibit 28: Product offerings for global colorectal cancer drugs market
Exhibit 29: Global colorectal cancer drugs market 2015-2020 ($ billions)
Exhibit 30: Products offerings for global NSCLC drugs market
Exhibit 31: Global NSCLC drugs market 2015-2020 ($ billions)
Exhibit 32: Product offerings for global prostate cancer drugs market
Exhibit 33: Global prostate cancer drugs market 2015-2020 ($ billions)
Exhibit 34: Product offerings for global kidney cancer drugs market
Exhibit 35: Global kidney cancer drugs market 2015-2020 ($ billions)
Exhibit 36: Product offerings for global retinoblastoma drugs market
Exhibit 37: Global retinoblastoma drugs market 2015-2020 ($ billions)
Exhibit 38: Product offerings for global cervical cancer market
Exhibit 39: Global cervical cancer market 2015-2020 ($ billions)
Exhibit 40: Product offerings for global melanoma drugs market
Exhibit 41: Global melanoma drugs market 2015-2020 ($ billions)
Exhibit 42: Products offerings for global gastric cancer drugs market
Exhibit 43: Global gastric cancer drugs market 2015-2020 ($ billions)
Exhibit 44: Products offerings for global pancreatic cancer drugs market
Exhibit 45: Global pancreatic cancer drugs market 2015-2020 ($ billions)
Exhibit 46: Products offerings for global ovarian cancer drugs market
Exhibit 47: Global ovarian cancer drugs market 2015-2020 ($ billions)
Exhibit 48: Product offerings for global liver cancer drugs market
Exhibit 49: Global liver cancer drugs market 2015-2020 ($ billions)
Exhibit 50: Products offerings for global HL drugs market
Exhibit 51: Global HL drugs market 2015-2020 ($ millions)
Exhibit 52: Products offerings for global glioblastoma multiforme drugs market
Exhibit 53: Global glioblastoma multiforme drugs market 2015-2020 ($ millions)
Exhibit 54: Global solid tumors drugs market by geography 2015
Exhibit 55: Global solid tumors drugs market revenue by geography 2015-2020 ($ billions)
Exhibit 56: Global solid tumors drugs market revenue by geography 2015-2020
Exhibit 57: Solid tumors drugs market in Americas 2015-2020 ($ billions)
Exhibit 58: Solid tumors drugs market in EMEA 2015-2020 ($ billions)
Exhibit 59: Solid tumors drugs market in APAC 2015-2020 ($ billions)
Exhibit 60: Global solid tumors drugs market: YoY revenue and growth based on geography 2015-2020 ($ billions)
Exhibit 61: Global incidence of solid tumor types 2015
Exhibit 62: Global mortality of solid tumor types 2015
Exhibit 63: Impact of drivers
Exhibit 64: Patent expiries of major cancer monoclonal antibodies by 2020
Exhibit 65: Average cost comparison of Herceptin 2014
Exhibit 66: Impact of drivers and challenges
Exhibit 67: Expected combination regimen launches in oncology
Exhibit 68: YoY Sales comparison of top drugs 2013-2015 ($ billions)
Exhibit 69: Ranking of major vendors for global solid tumors drugs market
Exhibit 70: Market share analysis of global solid tumors drugs market 2015
Exhibit 71: F. Hoffmann-La Roche: YoY growth and revenue generated from total product sales of MabThera/Rituxan (oncology indications) 2013-2015 ($ billions)
Exhibit 72: MabThera/Rituxan geographic segmentation by revenue 2015
Exhibit 73: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Avastin 2013-2015 ($ billions)
Exhibit 74: F. Hoffmann-La Roche: Geographic segmentation of Avastin by revenue 2015
Exhibit 75: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Herceptin 2013-2015 ($ billions)
Exhibit 76: F. Hoffmann-La Roche: Geographical segmentation of Herceptin 2015
Exhibit 77: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Perjeta 2013-2015 ($ billions)
Exhibit 78: F. Hoffmann-La Roche: Geographical segmentation of Perjeta 2015
Exhibit 79: F. Hoffmann-La Roche: Revenue generated from net product sales of Kadcyla 2013-2015 ($ millions)
Exhibit 80: F. Hoffmann-La Roche: Geographical segmentation of Kadycla 2015
Exhibit 81: F. Hoffmann-La Roche: Revenue generated from net product sales of Tarceva 2013-2015 ($ billions)
Exhibit 82: F. Hoffmann-La Roche: Geographical segmentation of Tarceva 2015
Exhibit 83: F. Hoffmann-La Roche: Key takeaways
Exhibit 84: Novartis: YoY revenue and growth rate of Gleevec 2013-2015 ($ billions)
Exhibit 85: Novartis: YoY revenue and growth rate of Sandostatin 2013-2015 ($ billions)
Exhibit 86: Novartis: YoY revenue and growth rate of Sandostatin 2013-2015 ($ billions)
Exhibit 87: Novartis: Key takeaways
Exhibit 88: Celgene: YoY revenue and growth rate of Revlimid 2013-2015 ($ billions)
Exhibit 89: Celgene: YoY revenue and growth rate of Abraxane 2013-2015 ($ millions)
Exhibit 90: Celgene: YoY revenue and growth rate of Istodax 2013-2015 ($ millions)
Exhibit 91: Celgene: YoY revenue and growth rate of Pomalyst 2013-2015 ($ millions)
Exhibit 92: Celgene: YoY revenue and growth rate of Pomalyst 2013-2015 ($ millions)
Exhibit 93: Celgene: Key takeaways
Exhibit 94: Johnson & Johnson: YoY revenue comparison of Zytiga 2013-2015 ($ billions)
Exhibit 95: Johnson & Johnson: YoY revenue comparison of Velcade 2013-2015 ($ billions)
Exhibit 96: Johnson & Johnson: YoY revenue comparison of Imbruvica 2014-2015 ($ millions)
Exhibit 97: Key takeaways
Exhibit 98: Pfizer: YoY revenue and growth rate of Sutent 2013-2015 ($ billions)
Exhibit 99: Pfizer: YoY revenue and growth rate of Xalkori 2013-2015 ($ millions)
Exhibit 100: Pfizer: YoY revenue and growth rate of Inlyta 2013-2015 ($ millions)
Exhibit 101: Key takeaways
Exhibit 102: BMS: YoY revenue and growth rate of Erbitux 2013-2015 ($ millions)
Exhibit 103: BMS: YoY revenue and growth rate of Sprycel 2013-2015 ($ billions)
Exhibit 104: Key takeaways


【レポート販売概要】

■ タイトル:固形腫瘍治療薬の世界市場2016-2020
■ 英文:Global Solid Tumors Drugs Market 2016-2020
■ 発行日:2016年6月24日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9801
■ 調査対象地域:グローバル
  • オレオケミカル(油脂化学品)の世界市場:脂肪酸、脂肪アルコール、グリセリン
    The oleochemicals market is projected to register a CAGR of 4.20% between 2014 and 2019 to reach $25,917.57 million by 2019. Asia-Pacific held the largest share in 2013 with China being the leading country. In the more saturated markets of North America and Europe, low growth is expected while the developing regions of Asia-Pacific are predicted to show high growth. Growth in the North American re …
  • モバイル暗号化の世界市場予測(~2022年):ディスク暗号化、ファイル/フォルダ暗号化、通信暗号化、クラウド暗号化
    “Need for stringent compliance and increasing concern for data security are driving the mobile encryption market.”The mobile encryption market size is expected to grow from USD 761.4 million in 2017 to USD 2,917.9 million by 2022, at a Compound Annual Growth Rate (CAGR) of 30.8%. The market is driven by factors such as increased concerns for data security and privacy issues, the proliferation of s …
  • Von Willebrand Disease:グローバル臨床試験レビューH2, 2013
    Von Willebrand Disease Global Clinical Trials Review, H2, 2013 Summary GlobalData's clinical trial report, “Von Willebrand Disease Global Clinical Trials Review, H2, 2013" provides data on the Von Willebrand Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Von Willebrand Disease. It includes an overview of the trial numbers and …
  • カナダの滅菌器市場見通し(~2021)
    Canada Sterilization Equipment Market Outlook to 2021 Summary GlobalData’s new report, "Canada Sterilization Equipment Market Outlook to 2021", provides key market data on the Canada Sterilization Equipment market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Chemical Sterilizers, Physical Sterilizers and U …
  • スマートバンパーの世界市場2018-2022
    About Smart Bumper A smart or intelligent bumper is a structure designed to absorb the impact of a road accident and offer protection to various pedestrian safety and driver assistance systems. Smart bumper has an integrated radar, front grill with de-icing system, lighting system based on flexible optical fibers, along with impact detection and absorption system. Technavio’s analysts forecast the …
  • スマートグリッド市場におけるクラウドコンピューティング技術
    Cloud Computing: Cornerstone of the Next Generation of Smart-Grid Information Technology Summary Cloud computing is emerging as an ideal method of hosting and providing services over the internet, and is available in the form of private, public, combined, or hybrid cloud deployment models. It has a number of benefits for smart grid applications, such as cost-effectiveness, scalability and flexibil …
  • 医薬品卸売・物流の世界市場予測2016-2026
    Pharma Wholesaling and Distribution – Analysis of Companies, Trends and Future Revenues to Benefit Your Influence What does the future hold for drug wholesale and distribution (W&D) services? Discover revenue predictions there to 2026. And explore trends in those services and technologies, assessing prospects and finding opportunities to benefit your work and authority. In visiongain’s new report …
  • アメリカの魚油製品市場
    About Fish Oil Products in the US Fish oil is derived from tissues of oily fish species and contains a high percentage of long chain omega-3 fatty acids, such as EPA and DHA. These omega-3 fatty acids are essential nutrients for humans and animals. Fish oil is mainly used as a feed ingredient in many animal and human nutritional applications that include aquaculture feed, pharmaceuticals, animal n …
  • 世界の工業用ファスナー市場動向(2014-2018)
    About Industrial Fasteners Industrial fasteners are efficient tools used to connect two or more parts, enabling the development of superior-quality and reliable products. Various types of industrial fasteners such as externally threaded, standard, and aerospace grade fasteners are used across sectors such as Automotive, Industrial Machinery, Maintainence, Repair, and Overhauling, Aerospace and Def …
  • 世界の医療用クラウドコンピューティング市場:製品別(EMR / EHR、PACS、VNA、PHM、テレヘルス、RCM、CRM、不正管理)、サービス別(SaaS、IaaS)、展開別(プライベートクラウド、ハイブリッドクラウド)、価格別(現金払い)、コンポーネント別(ソフトウェア)
    “The global healthcare cloud computing market is projected to grow at a CAGR of 17.2% during the forecast period (2019–2024).” The global healthcare cloud computing market size is projected to reach USD 51.9 billion by 2024, from an estimated USD 23.4 billion in 2019 at a CAGR of 17.2% during the forecast period. The key factors driving the growth of this market include the increasing adoption of …
  • グローバルにおける風力タービン用ギアボックス市場(2014-2018)
    About Wind Turbine Gearbox A gearbox is used in a wind turbine to increase the rotational speed from a low-speed rotor to a higher speed electrical generator. The gearbox in the wind turbine does not change gears; it has a single gear ratio between the rotation of the rotor and the generator. The main purpose of using a gearbox in a wind turbine is to increase the efficiency, as different parts of …
  • 商業用HVAC(暖房・換気・空調)装置の世界市場2016
    About Commercial HVAC HVAC systems enhance air quality in commercial establishments through ventilation and filtration, thereby ensuring thermal balance in the environment. These systems use heat exchangers, pumps, and fans to control and regulate humidity and temperature levels. Parameters such as heating and cooling, along with the air quality of the outdoor or indoor environment determine the t …
  • Ergon, Inc.:石油・ガスバリューチェーン分析レポート2013
    Ergon, Inc. Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Ergon, Inc." Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Ergon, Inc.”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business …
  • 個人用保護具(PPE)の世界市場2016-2020
    About PPE Market The global PPE market is primarily driven by an increase in the demand from APAC, where international companies are initiating stringent safety programs in their countries of operation. Certain countries in this region, such as Japan, Australia, and New Zealand, have well-defined government regulations on worker safety, which contribute to market growth. The manufacturing and cons …
  • Gassco AS:石油・ガスバリューチェーン分析レポート2013
    Gassco AS Analysis Across the Oil and Gas Value Chain Report, 2013 Update Summary "Gassco AS" Analysis Across the Oil and Gas Value Chain is an essential source for data, analysis and strategic insight into “Gassco AS”. The report provides key information relating to oil and gas assets of the company along with its operations across the value chain. The report examines the company’s business struc …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。